Drug Trial Radar · NCT03053869
Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free)
Last checked: Nov 19, 2026Latest source record: Oct 16, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
480
Actual
Start
Apr 1, 2017
Primary completion
Sep 30, 2018
Study completion Sep 30, 2018
Sponsor
- Lead sponsor
- McMaster UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Hamilton Health Sciences Corporation
- First posted
- Feb 15, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this two-centre pilot research study is to establish the feasibility of conducting a full trial that seeks to determine if a cardiac anesthesia policy that uses alternatives to benzodiazepine medications is better at preventing delirium after cardiac surgery when compared with a cardiac anesthesia policy that uses benzodiazepine medications.
Conditions
- Post-operative Delirium
Interventions
Benzodiazepine - limited use strategyDrug
1. No routine use of any intraoperative benzodiazepines. 2. Accepted benzodiazepine use in the case of seizure, alcohol withdrawal, or known benzodiazepine dependence. 3. Accepted benzodiazepine use in patients who are hemodynamically unstable and/or have cardiac anatomy that puts them at high risk of developing ischemia on induction of anesthesia.
Benzodiazepine - Ad libitum strategyDrug
1. Administration of some benzodiazepine to most patients undergoing cardiac surgery. 2. Accepted lack of benzodiazepine use in patients who have contraindications to the administration of these medications (e.g. documented allergy).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Confusion Assessment Method (CAM) assessmentTime frame: 1 day
- Completion of a minimum of at least 1 CAM assessment per dayTime frame: 1 day
- Protocol adherenceTime frame: 4-week crossover period
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
St. Boniface Hospital
Winnipeg, Manitoba, Canada
Dr Summer Syed
Hamilton, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.